PD Dr. Peter Dietrich

Medizinische Fakultät Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Lehrstuhl für Biochemie und Molekulare Medizin

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort (2022) Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, et al. Journal article Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study. (2022) Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, et al. Journal article Therapy adaption by dose titration of obeticholic acid in a 57-year-old female patient with PBC and advanced liver fibrosis (2021) Vetter M, Dietrich P, Kremer A Conference contribution Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms (2021) Weindl L, Atreya I, Dietrich P, Neubeck S, Neurath M, Pavel ME Journal article Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11 (2021) Gaza A, Fritz V, Malek L, Wormser L, Treiber N, Danner J, Kremer AE, et al. Journal article Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus (2021) Düll M, Wolf K, Vetter M, Dietrich P, Neurath M, Kremer A Journal article Combined de‐repression of chemoresistance associated mitogen‐activated protein kinase 14 and activating transcription factor 2 by loss of microrna‐622 in hepatocellular carcinoma (2021) Fritz V, Malek L, Gaza A, Wormser L, Appel M, Kremer A, Thasler WE, et al. Journal article Xanthohumol, a prenylated chalcone derived from hops, inhibits growth and metastasis of melanoma cells (2021) Seitz T, Hackl C, Freese K, Dietrich P, Mahli A, Thasler RM, Thasler WE, et al. Journal article Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Journal article Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma (2020) Seitz T, Freese K, Dietrich P, Thasler WE, Boßerhoff AK, Hellerbrand C Journal article